Nanjing Pharmaceutical: Net profit of 625 million yuan in 2025, a year-on-year increase of 9.50%.

Nanjing Pharmaceutical announced that in 2025, its operating income will reach 54.963 billion yuan, an increase of 2.36% year-on-year; net profit will be 625 million yuan, an increase of 9.50% year-on-year. The company's profit distribution plan for 2025 is to distribute a cash dividend of 1.7 yuan per 10 shares to all shareholders.